GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Earnings per Share (Diluted)
中文

Embla Medical hf (OCSE:EMBLA) Earnings per Share (Diluted) : kr0.93 (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Earnings per Share (Diluted)?

Embla Medical hf's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was kr0.13. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.93.

Embla Medical hf's EPS (Basic) for the three months ended in Mar. 2024 was kr0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.93.

Embla Medical hf's EPS without NRI for the three months ended in Mar. 2024 was kr0.13. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.93.

During the past 12 months, Embla Medical hf's average EPS without NRIGrowth Rate was 32.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 119.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was -0.40% per year.

During the past 13 years, Embla Medical hf's highest 3-Year average EPS without NRI Growth Rate was 238.30% per year. The lowest was -56.80% per year. And the median was 8.50% per year.


Embla Medical hf Earnings per Share (Diluted) Historical Data

The historical data trend for Embla Medical hf's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Earnings per Share (Diluted) Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 0.09 1.02 0.72 0.96

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.26 0.23 0.31 0.13

Competitive Comparison of Embla Medical hf's Earnings per Share (Diluted)

For the Medical Devices subindustry, Embla Medical hf's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's PE Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's PE Ratio falls into.



Embla Medical hf Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Embla Medical hf's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(399.077-0)/420.318
=0.95

Embla Medical hf's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(56.662-0)/434.737
=0.13

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Embla Medical hf  (OCSE:EMBLA) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Embla Medical hf Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines